Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 116, Issue 5, 2013, Pages 562-569

  Sanitá, Paula Volpato ^a   De Oliveira Mima, Ewerton Garcia ^a   Pavarina, Ana Cláudia ^a   Jorge, Janaina Habib ^a   Machado, Ana Lúcia ^a   Vergani, Carlos Eduardo ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE;

ANTIFUNGAL RESISTANCE; ARTICLE; BRAZIL; CANDIDA; CLASSIFICATION; DIABETES MELLITUS; DRUG EFFECT; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; STOMATITIS; THRUSH;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDIASIS, ORAL; DIABETES MELLITUS; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; STOMATITIS, DENTURE;

EID: 84885427530     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2013.07.002     Document Type: Article

References (59)

1. A. Akpan, and R. Morgan Oral candidiasis Postgrad Med J 78 2002 455 459
2. E.G. Mima, C.E. Vergani, and A.L. Machado Comparison of photodynamic therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial Clin Microbiol Infect 18 2012 E380 E388
3. P.V. Sanitá, A.C. Pavarina, and E.T. Giampaolo Candida spp. prevalence in well controlled type 2 diabetic patients with denture stomatitis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111 2011 726 733
4. P.V. Sanitá, A.L. Machado, A.C. Pavarina, E.M. Massucato, A.L. Colombo, and C.E. Vergani Microwave denture disinfection versus nystatin in treating patients with well-controlled type 2 diabetes and denture stomatitis: a randomized clinical trial Int J Prosthodont 25 2012 232 244
5. M.M. Silva, E.G. Mima, and A.L. Colombo Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study Oral Surg Oral Med Oral Pathol Oral Radiol 114 2012 469 479
6. A.S. Melo, F.C. Bizerra, E. Freymüller, B.A. Arthington-Skaggs, and A.L. Colombo Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex Med Mycol 49 2011 253 262
7. Z. Jackson, S. Meghji, A. MacRobert, B. Henderson, and M. Wilson Killing of the yeast and hyphal forms of Candida albicans using a light-activated antimicrobial agent Lasers Med Sci 14 1999 150 157
8. M. Belazi, A. Velegraki, and A. Fleva Candidal overgrowth in diabetic patients: potential predisposing factors Mycoses 48 2005 192 196
9. S.E. Geerlings, and A.I. Hoepelman Immune dysfunction in patients with diabetes mellitus (DM) FEMS Immunol Med Microbiol 26 1999 259 265
10. C.A. Negrato, and O. Tarzia Buccal alterations in diabetes mellitus Diabetol Metab Syndr 2 2010 3
11. A.M.G. Darwazeh, P.J. Lamey, and L.P. Samaranayake The relationship between colonisation, secretor status and in vitro adhesion of Candida albicans to buccal epithelial cells from diabetics J Med Microbiol 33 1990 43 49
12. B. Dorocka-Bobkowska, E. Budtz-Jorgensen, and S. Wloch Non-insulin-dependent diabetes mellitus as a risk factor for denture stomatitis J Oral Pathol Med 25 1996 411 415
13. M.A. Pfaller Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment Am J Med 125 1 suppl 2012 S3 S13
14. S.A. Al-Attas, and S.O. Amro Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients Ann Saudi Med 30 2010 101 108
15. R.M. Bremenkamp, A.R. Caris, and A.O. Jorge Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus Arch Oral Biol 56 2011 549 555
16. M.L. Cameron, W.A. Schell, S. Bruch, J.A. Bartlett, H.A. Waskin, and J.R. Perfect Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1 Antimicrob Agents Chemother 37 1993 2449 2453
17. A.R. Costa, M.E. Rodrigues, and F. Silva MIC evaluation of Candida reference strains and clinical isolates by E-test J Chemother 21 2009 351 355
18. P.D. Diz-Dios, A.J. Alvarez, F.J. Fernandez, and F.M. Castro Fluconazole response patterns in HIV-infected patients with oropharyngeal candidiasis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 1995 170 174
19. G.H. Goldman, M.E.S. Ferreira, and E.R. Marques Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil Diagn Microbiol Infect Dis 50 2004 25 32
20. K.D. Hunter, J. Gibson, P. Lockhart, A. Pithie, and J. Bagg Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients Oral Surg Oral Med Oral Pathol 85 1998 558 564
21. G. Kovacicova, Y. Krupova, and M. Lovaszova Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia? J Infect Chemother 6 2000 216 221
22. M. Martinez, J.L. López-Ribot, W.R. Kirkpatrick, B.J. Coco, S.P. Bachmann, and T.F. Patterson Replacement of Candida albicans with Candida dubliniensis in Human Immunodeficiency Virus-infected patients with oropharyngeal candidiasis treated with fluconazole J Clin Microbiol 40 2002 3135 3139
23. M. Negri, M. Henriques, T.I. Svidzinski, C.R. Paula, and R. Oliveira Correlation between Etest, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization J Clin Lab Anal 23 2009 324 330
24. N. Triollet, C. Durussel, J. Bille, M.P. Glauser, and J.P. Chave Correlation between in vitro susceptibility of Candida albicans and fluconazole resistant oropharyngeal candidiasis in HIV infected patients Eur J Clin Microbiol Infect Dis 12 1993 911 915
25. D.W. Denning Echinocandins: a new class of antifungal J Antimicrob Chemother 49 2002 889 891
26. S. Maesaki, M.A. Hossain, Y. Miyazaki, K. Tomono, T. Tashiro, and S. Kohno Efficacy of FK463, a (1,3)-beta-D-glucan synthase inhibitor, in disseminated azole-resistant Candida albicans infection in mice Antimicrob Agents Chemother 44 2000 1728 1730
27. A.L. Motta, G.M. Almeida, J.N. Almeida Júnior, M.N. Burattini, and F. Rossi Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex Braz J Infect Dis 14 2010 441 448
28. C. Marcos-Arias, E. Eraso, L. Madariaga, A.J. Carrillo-Muñoz, and G. Quindós In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis Mycopathologia 173 2012 35 46
29. E. Pinto, I.C. Ribeiro, N.J. Ferreira, C.E. Fortes, P.A. Fonseca, and M.H. Figueiral Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals J Oral Pathol Med 37 2008 587 592
30. M. Manfredi, M.J. McCullough, and L. Polonelli In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus Oral Microbiol Immunol 21 2006 177 182
31. D.G. Ribeiro, A.C. Pavarina, L.N. Dovigo, D.M. Palomari Spolidorio, E.T. Giampaolo, and C.E. Vergani Denture disinfection by microwave irradiation: a randomized clinical study J Dent 37 2009 666 672
32. S.H. Alves, E.P. Milan, P. de Laet-Sant'Ana, L.O. Oliveira, J.M. Santurio, and A.L. Colombo Hypertonic Sabouraud broth as a simple and powerful test for Candida dubliniensis screening Diagn Microbiol Infect Dis 43 2002 85 86
33. Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard, M27-A3.Vol 28. No. 14 3rd ed. 2008 Clinical and Laboratory Standards Institute Wayne, PA
34. P. Godoy, I.N. Tiraboschi, and L.C. Severo Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals Mem Inst Oswaldo Cruz 98 2003 401 405
35. J. Blomgren, U. Berggren, and M. Jontell Fluconazole versus nystatin in the treatment of oral candidiasis Acta Odontol Scand 56 1998 202 205
36. V.L. Bosco, E.G. Birman, A.E. Cury, and C.R. Paula Yeasts from the oral cavity of children with AIDS: exoenzyme production and antifungal resistance Pesqui Odontol Bras 17 2003 217 222
37. A. Davies, S. Brailsford, K. Broadley, and D. Beighton Resistance amongst yeasts isolated from the oral cavities of patients with advanced cancer Palliat Med 16 2002 527 531
38. C.R. Costa, J.A. de Lemos, and X.S. Passos Species distribution and antifungal susceptibility profile of oral Candida isolates from HIV-infected patients in the antiretroviral therapy era Mycopathologia 162 2006 45 50
39. S. Silva, M. Henriques, A. Hayes, R. Oliveira, J. Azeredo, and D.W. Williams Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium J Oral Pathol Med 40 2011 421 427
40. B.J. Coco, J. Bagg, L.J. Cross, A. Jose, J. Cross, and G. Ramage Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis Oral Microbiol Immunol 23 2008 377 383
41. S.F. Costa, I. Marinho, E.A. Araújo, A.E. Manrique, E.A. Medeiros, and A.S. Levin Nosocomial fungaemia: a 2-year prospective study J Hosp Infect 45 2000 69 72
42. F. Meunier-Carpentier, T.E. Kiehn, and D. Armstrong Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality Am J Med 71 1981 363 370
43. C.Y. Koga-Ito, J.P. Lyon, V. Vidotto, and M.A. de Resende Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidiasis patients and control individuals Mycopathologia 161 2006 219 223
44. S. Carvalhinho, A.M. Costa, A.C. Coelho, E. Martins, and A. Sampaio Susceptibilities of Candida albicans mouth isolates to antifungal agents, essential oils and mouthrinses Mycopathologia 174 2012 69 76
45. M.A. Ghannoum, and L.B. Rice Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance Clin Microbiol Rev 12 1999 501 517
46. A.J. Carrillo-Muñoz, G. Giusiano, P.A. Ezkurra, and G. Quindós Antifungal agents: mode of action in yeast cells Rev Esp Quimioter 19 2006 130 139
47. A.N. Ellepola, and L.P. Samaranayake The effect of limited exposure to antimycotics on the relative cell-surface hydrophobicity and the adhesion of oral Candida albicans to buccal epithelial cells Arch Oral Biol 43 1998 879 887
48. J.P. Lyon, and M.A. Resende Evaluation of adhesion to buccal epithelial cells in Candida species obtained from denture wearers after exposure to fluconazole Mycoses 50 2007 21 24
49. A.M. Willis, W.A. Coulter, C.R. Fulton, J.R. Hayes, P.M. Bell, and P.J. Lamey The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 2001 317 321
50. A.N. Ellepola, and L.P. Samaranayake Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents Arch Oral Biol 43 1998 999 1007
51. J.B. Epstein, E.L. Truelove, and K. Hanson-Huggins Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy Support Care Cancer 12 2004 517 525
52. S. Kohno, K. Izumikawa, and M. Yoshida A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis Eur J Clin Microbiol Infect Dis 32 2013 387 397
53. S.C. Chen, M.A. Slavin, and T.C. Sorrell Echinocandin antifungal drugs in fungal infections: a comparison Drugs 71 2011 11 41
54. A. Villanueva, E. Gotuzzo, and E.G. Arathoon A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis Am J Med 113 2002 294 299
55. M.A. Pfaller, L. Boyken, and R.J. Hollis In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance J Clin Microbiol 46 2008 150 156
56. D.M. Kuhn, T. George, J. Chandra, P.K. Mukherjee, and M.A. Ghannoum Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins Antimicrob Agents Chemother 46 2002 1773 1780
57. G. Kyselgof, H. Sandovsky-Losica, I. Berdicevsky, and E. Segal Caspofungin affects adhesion of Candida to a human cell line J Mycol Med 17 2007 1 7
58. S. Ranque, L. Lachaud, and M. Gari-Toussaint Interlaboratory reproducibility of Etest amphotericin B and caspofungin yeast susceptibility testing and comparison with the CLSI method J Clin Microbiol 50 2012 2305 2309
59. G. Morace, G. Amato, and F. Bistoni Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards M27-A broth microdilution method for fluconazole susceptibility testing of Candida species J Clin Microbiol 40 2002 2953 2958